FDA cracking down?

I wonder when the FDA will tell Novo to lower their insane prices here in the US... It's like $1500 a month. I heard it's less than $250 across the pond.
 
Who all is even in the GLP-1 game anyway?

Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim, Hanmi Pharm, Pfizer, Amgen. That's a lot of big pharma.

Hopefully, that means prices will come down eventually?
 
What does this all mean for us? I've got a good stash of my GLP but I'm running low on some of the other peptides I'm using now. Should I be stocking up more?
 
Honestly, probably not many options for individuals besides getting more while you can.
Lab_Lurker said:
What does this all mean for us?
Click to expand...
I feel like there are so many places selling this stuff now that the FDA couldn't shut them all down even if they wanted to. Especially the ones that aren't easy to find online.
 
I wanted to add a word of caution regarding GLP-1 medications and vision changes. There have been reports of visual disturbances, and even a very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION). If you experience sudden vision impairment or worsening vision, seek immediate medical attention. This is especially important for people with diabetes.
 
This is interesting because I saw a Reddit thread the other day about someone whose optometrist was kind of a jerk and attributed their vision changes to Ozempic.
Checkup said:
If you experience sudden vision impairment or worsening vision, seek immediate medical attention.
Click to expand...
Sounds like it could be a real concern!
 
I vaguely remember seeing something about vision problems, too. I think the UK even issued a warning about it. Sudden vision changes are scary!
 
You must log in or register to reply here.
Back
Top